Shares of Cerner Co. (NASDAQ:CERN) have been assigned an average recommendation of “Hold” from the seventeen brokerages that are covering the firm, Marketbeat.com reports. Two research analysts have rated the stock with a sell rating, five have assigned a hold rating and nine have issued a buy rating on the company. The average twelve-month target price among brokers that have updated their coverage on the stock in the last year is $80.00.
CERN has been the subject of a number of recent research reports. Argus increased their price objective on Cerner from $77.00 to $88.00 and gave the company a “buy” rating in a research report on Tuesday, December 29th. UBS Group downgraded Cerner from a “buy” rating to a “neutral” rating and set a $82.00 price objective for the company. in a research report on Thursday, February 11th. Bank of America downgraded shares of Cerner from a “buy” rating to an “underperform” rating in a research note on Tuesday, January 19th. Canaccord Genuity boosted their target price on shares of Cerner from $81.00 to $89.00 and gave the company a “buy” rating in a research note on Thursday, January 7th. Finally, Morgan Stanley boosted their target price on shares of Cerner from $64.00 to $70.00 and gave the company an “underweight” rating in a research note on Thursday, February 11th.
In other Cerner news, CFO Mark J. Erceg bought 10,547 shares of the stock in a transaction on Wednesday, March 10th. The shares were purchased at an average cost of $71.13 per share, with a total value of $750,208.11. Also, CFO Mark J. Erceg bought 10,761 shares of the stock in a transaction on Wednesday, March 3rd. The shares were acquired at an average cost of $69.66 per share, for a total transaction of $749,611.26. Insiders have acquired 31,963 shares of company stock worth $2,250,251 over the last three months. Company insiders own 0.33% of the company’s stock.
Shares of NASDAQ:CERN traded down $0.63 on Monday, reaching $74.68. 1,761,559 shares of the company traded hands, compared to its average volume of 2,429,866. Cerner has a fifty-two week low of $63.11 and a fifty-two week high of $84.20. The company’s 50 day moving average is $72.01 and its 200-day moving average is $74.63. The stock has a market capitalization of $22.57 billion, a PE ratio of 29.17, a P/E/G ratio of 2.35 and a beta of 0.76. The company has a debt-to-equity ratio of 0.30, a current ratio of 2.29 and a quick ratio of 2.28.
Cerner (NASDAQ:CERN) last announced its quarterly earnings data on Tuesday, February 9th. The company reported $0.78 EPS for the quarter, meeting analysts’ consensus estimates of $0.78. Cerner had a return on equity of 18.14% and a net margin of 14.28%. The company had revenue of $1.40 billion during the quarter, compared to the consensus estimate of $1.39 billion. During the same quarter in the prior year, the firm earned $0.75 EPS. The company’s quarterly revenue was down 3.3% compared to the same quarter last year. As a group, analysts expect that Cerner will post 2.47 EPS for the current year.
The business also recently declared a quarterly dividend, which will be paid on Tuesday, April 20th. Stockholders of record on Tuesday, April 6th will be paid a $0.22 dividend. This represents a $0.88 dividend on an annualized basis and a dividend yield of 1.18%. The ex-dividend date of this dividend is Monday, April 5th. Cerner’s dividend payout ratio (DPR) is presently 36.51%.
Cerner Corporation, together with its subsidiaries, provides health care information technology solutions and tech-enabled services in the United States and internationally. The company offers Cerner Millennium architecture, a person-centric computing framework, which includes clinical, financial, and management information systems that allow providers to access an individual's electronic health record (EHR) at the point of care, and organizes and delivers information for physicians, nurses, laboratory technicians, pharmacists, front- and back-office professionals, and consumers.
Featured Story: What is the Gross Domestic Product (GDP)?
Receive News & Ratings for Cerner Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cerner and related companies with MarketBeat.com's FREE daily email newsletter.